Gehazi: Profiting in African Christianity from diseases, poverty, demons and death
Integrated Biblical and Theological Studies · 2026
DOI: 10.4102/ibts.v2i1.6 ↗Kurz gefasst
Fachartikel in der Zeitschrift Integrated Biblical and Theological Studies, 2026. Verfasst von Favour C. Uroko. Die Arbeit nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
This article examines the spiritual merchandising in African Christianity in light of the narrative regarding Gehazi in the Old Testament. In Africa, faith-based healing and deliverance are performed on an exploitative basis and for personal enrichment. Many Africans experience physical and spiritual challenges, making them vulnerable in the hands of these exploitative prophets and pastors. These challenges are the reasons why religious leaders commercialise healing, deliverance, exorcism and prophecy. Existing literature has failed to address this issue through the lens of Gehazi in 2 Kings 5:20–27. This study adopts the narrative method, using data from the pericope and relevant academic literature. The study shows that under no circumstances should spiritual gifts be for sale. This study further shows that deception attracts God’s judgement. Furthermore, the narrative shows that greed corrupts one’s ministry. Contribution: The study highlights the importance of contentment. The church in Africa should prio
Zitieren
APA
Uroko, F. C. (2026). Gehazi: Profiting in African Christianity from diseases, poverty, demons and death. Integrated Biblical and Theological Studies. https://doi.org/10.4102/ibts.v2i1.6
Vancouver
Uroko FC. Gehazi: Profiting in African Christianity from diseases, poverty, demons and death. Integrated Biblical and Theological Studies. 2026. doi:10.4102/ibts.v2i1.6
BibTeX
@article{Uroko2026,
author = {Uroko, Favour C.},
title = {Gehazi: Profiting in African Christianity from diseases, poverty, demons and death},
journal = {Integrated Biblical and Theological Studies},
year = {2026},
doi = {10.4102/ibts.v2i1.6}
}
EUVIMED